Dr. Mahajan’s lab provides an immersive, intensive training environment for students and fellows to discover the molecular mechanisms that cause blindness and develop therapies to prevent vision loss. Highly collaborative research teams are made up of scientists, surgeons, and engineers from around the world, interacting on a daily basis and using advanced scientific methods.
Angela Li was a medical student at Stanford University. She joined the lab in 2018 and applied bioinformatic tools to characterize genetic eye diseases. She is interested in functional genomics and proteomics, translational bioinformatics, precision medicine, and diseases of the eye. She is currently an ophthalmology resident at Duke Univeristy and continues to work on proteotype-phenotype relationships in genetic eye disease.
Benjamin received his B.A. from the University of Cambridge in 2016. He is in medical school at Christ Church, University of Oxford and plans to graduate in 2019. He received a competitive grant from the Oxford University Clinical Academic Graduate School to help fund a medical elective in Dr. Mahajan's lab where he researches the proteomics of wet age-related macular degeneration.